The genetics and genomics of cancer (original) (raw)

• Knudson, A.G. Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68, 820–823 (1971).
  Article PubMed PubMed Central Google Scholar
• Friend, S.H. et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323, 643–646 (1986).
  Article CAS PubMed Google Scholar
• Doll, R. & Peto, R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66, 1191–1308 (1981).
  Article CAS PubMed Google Scholar
• Peto, J. Cancer epidemiology in the last century and the next decade. Nature 411, 390–395 (2001).
  Article CAS PubMed Google Scholar
• Buell, P. & Dunn, J.E. Cancer mortality among Japanese Issei and Nisei of California. Cancer 18, 656–664 (1965).
  Article CAS PubMed Google Scholar
• Newman, B., Austin, M.A., Lee, M. & King, M.C. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc. Natl. Acad. Sci. USA 85, 3044–3048 (1988).
  Article CAS PubMed PubMed Central Google Scholar
• Claus, E.B., Risch, N. & Thompson, W.D. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum. Genet. 48, 232–242 (1991).
  CAS PubMed PubMed Central Google Scholar
• Peto, J. in Cancer Incidence in Defined Populations Vol. 4, Banbury Report (eds. Cairns, J., Lyon, J.L. & Skolnik, M.) 203–213 (Cold Spring Harbor Press, Cold Spring Harbor, NY, 1980).
  Google Scholar
• Hall, J.M. et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684–1689 (1990).
  Article CAS PubMed Google Scholar
• Weinberg, R.A. The retinoblastoma protein and cell cycle control. Cell 81, 323–330 (1995).
  Article CAS PubMed Google Scholar
• Linzer, D.I. & Levine, A.J. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17, 43–52 (1979).
  Article CAS PubMed Google Scholar
• Lane, D.P. & Crawford, L.V. Tantigen is bound to a host protein in SV40-transformed cells. Nature 278, 261–263 (1979).
  Article CAS PubMed Google Scholar
• Baker, S.J. et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244, 217–221 (1989).
  Article CAS PubMed Google Scholar
• Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233–1238 (1990).
  Article CAS PubMed Google Scholar
• Kinzler, K.W. & Vogelstein, B. Colorectal tumors. In The Genetic Basis of Human Cancer (ed. Kinzler, K.W.) 583–612 (McGraw Hill, New York 2002).
  Google Scholar
• Stambolic, V. et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29–39 (1998).
  Article CAS PubMed Google Scholar
• Eng, C. & Parsons, R. Cowden syndrome. In The Genetic Basis of Human Cancer (ed. Kinzler, K.W.) 527–537 (McGraw Hill, New York 2002).
  Google Scholar
• Linehan, W.M., Zbar, B. & Klausner, R.D. Renal cancer. In The Genetics Basis of Human Cancer (ed. Kinzler, K.W.) 449–474 (McGraw Hill, New York 2002).
  Google Scholar
• Venkitaraman, A.R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108, 171–182 (2002).
  Article CAS PubMed Google Scholar
• Hoeijmakers, J.H. Genome maintenance mechanisms for preventing cancer. Nature 411, 366–374 (2001).
  Article CAS PubMed Google Scholar
• Schor, S.L., Schor, A.M., Durning, P. & Rushton, G. Skin fibroblasts obtained from cancer patients display foetal-like migratory behaviour on collagen gels. J. Cell Sci. 73, 235–244 (1985).
  CAS PubMed Google Scholar
• Olumi, A.F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002–5011 (1999).
  CAS PubMed Google Scholar
• Kurose, K. et al. Frequent somatic mutations in PTEN. and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat. Genet. 32, 355–357 (2002).
  Article CAS PubMed Google Scholar
• Zhu, Y., Ghosh, P., Charnay, P., Burns, D.K. & Parada, L.F. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296, 920–922 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Holtzman, N.A. & Marteau, T.M. Will genetics revolutionize medicine? N. Engl. J. Med. 343, 141–144 (2000).
  Article CAS PubMed Google Scholar
• Bell, J. The new genetics in clinical practice. Br. Med. J. 316, 618–620 (1998).
  Article CAS Google Scholar
• Pharoah, P.D. et al. Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet. 31, 33–36 (2002).
  Article CAS PubMed Google Scholar
• Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78–85 (2000).
  Article CAS PubMed Google Scholar
• Cui, J. et al. After BRCA1 and BRCA2—what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am. J. Hum. Genet. 68, 420–31 (2001).
  Article CAS PubMed Google Scholar
• Antoniou, A.C. et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br. J. Cancer 86, 76–83 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Peto, J. Breast cancer susceptibility—a new look at an old model. Cancer Cell 1, 411–412 (2002).
  Article CAS PubMed Google Scholar
• Wright, A.F. & Hastie, N.D. Complex genetic diseases: controversy over the Croesus code. Genome Biol. 2, COMMENT2007 (2001).
• Cardon, L.R. & Bell, J.I. Association study designs for complex diseases. Nat. Rev. Genet. 2, 91–99 (2001).
  Article CAS PubMed Google Scholar
• Botstein, D. & Rich, N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat. Genet., 33, 228–237 (2003)
  Article CAS PubMed Google Scholar
• Gabriel, S.B. et al. The structure of haplotype blocks in the human genome. Science 296, 2225–2229 (2002).
  Article CAS PubMed Google Scholar
• Couzin, J. Genomics. New mapping project splits the community. Science 296, 1391–3139 (2002).
  Article CAS PubMed Google Scholar
• Horikawa, Y. et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26, 163–175 (2000).
  Article CAS PubMed Google Scholar
• Balmain, A. & Nagase, H. Cancer resistance genes in mice: models for the study of tumour modifiers. Trends Genet. 14, 139–144 (1998).
  Article CAS PubMed Google Scholar
• Tripodis, N., Hart, A.A., Fijneman, R.J. & Demant, P. Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. J. Natl. Cancer Inst. 93, 1484–1491 (2001).
  Article CAS PubMed Google Scholar
• Nagase, H., Mao, J.H. & Balmain, A. A subset of skin tumor modifier loci determines survival time of tumor-bearing mice. Proc. Natl. Acad. Sci. USA 96, 15032–15037 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Saran, A. et al. Genetics of chemical carcinogenesis: analysis of bidirectional selective breeding inducing maximal resistance or maximal susceptibility to 2-stage skin tumorigenesis in the mouse. Int. J. Cancer 88, 424–431 (2000).
  Article CAS PubMed Google Scholar
• Fijneman, R.J., de Vries, S.S., Jansen, R.C. & Demant, P. Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat. Genet. 14, 465–467 (1996).
  Article CAS PubMed Google Scholar
• van Wezel, T. et al. Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat. Genet. 14, 468–470 (1996).
  Article CAS PubMed Google Scholar
• Nagase, H., Mao, J.H., de Koning, J.P., Minami, T. & Balmain, A. Epistatic interactions between skin tumor modifier loci in interspecific (spretus/musculus) backcross mice. Cancer Res. 61, 1305–1308 (2001).
  CAS PubMed Google Scholar
• Rouse, J. & Jackson, S.P. Interfaces between the detection, signaling, and repair of DNA damage. Science 297, 547–551 (2002).
  Article CAS PubMed Google Scholar
• Kolodner, R.D., Putnam, C.D. & Myung, K. Maintenance of genome stability in Saccharomyces cerevisiae. Science 297, 552–557 (2002).
  Article CAS PubMed Google Scholar
• Maser, R.S. & DePinho, R.A. Connecting chromosomes, crisis, and cancer. Science 297, 565–569 (2002).
  Article CAS PubMed Google Scholar
• Lengauer, C., Kinzler, K.W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643–649 (1998).
  Article CAS PubMed Google Scholar
• Friedberg, E.C. How nucleotide excision repair protects against cancer. Nat. Rev. Cancer 1, 22–33 (2001).
  Article CAS PubMed Google Scholar
• Ionov, Y., Peinado, M.A., Malkhosyan, S., Shibata, D. & Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363, 558–561 (1993).
  Article CAS PubMed Google Scholar
• Thibodeau, S.N., Bren, G. & Schaid, D. Microsatellite instability in cancer of the proximal colon. Science 260, 816–819 (1993).
  Article CAS PubMed Google Scholar
• Parsons, R. et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75, 1227–1236 (1993).
  Article CAS PubMed Google Scholar
• Lynch, H.T. & de la Chapelle, A. Genetic susceptibility to non-polyposis colorectal cancer. J. Med. Genet. 36, 801–818 (1999).
  CAS PubMed PubMed Central Google Scholar
• Rampino, N. et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275, 967–969 (1997).
  Article CAS PubMed Google Scholar
• Parsons, R. et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res. 55, 5548–5550 (1995).
  CAS PubMed Google Scholar
• Hastie, N.D. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866–868 (1990).
  Article CAS PubMed Google Scholar
• Blackburn, E.H. & Challoner, P.B. Identification of a telomeric DNA sequence in Trypanosoma brucei. Cell 36, 447–457 (1984).
  Article CAS PubMed Google Scholar
• Cahill, D.P. et al. Mutations of mitotic checkpoint genes in human cancers. Nature 392, 300–303 (1998).
  Article CAS PubMed Google Scholar
• Jallepalli, P.V. & Lengauer, C. Chromosome segregation and cancer: cutting through the mystery. Nat. Rev. Cancer 1, 109–117 (2001).
  Article CAS PubMed Google Scholar
• Fodde, R., Smits, R. & Clevers, H. APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 1, 55–67 (2001).
  Article CAS PubMed Google Scholar
• Bischoff, J.R. et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17, 3052–3065 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, H. et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 20, 189–193 (1998).
  Article CAS PubMed Google Scholar
• Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S. & Vande Woude, G.F. Abnormal centrosome amplification in the absence of p53. Science 271, 1744–1747 (1996).
  Article CAS PubMed Google Scholar
• Vogelstein, B., Lane, D. & Levine, A.J. Surfing the p53 network. Nature 408, 307–310 (2000).
  Article CAS PubMed Google Scholar
• Fearon, E.R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).
  Article CAS PubMed Google Scholar
• Nowell, P.C. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976).
  Article CAS PubMed Google Scholar
• Frame, S. & Balmain, A. Integration of positive and negative growth signals during ras pathway activation in vivo. Curr. Opin. Genet. Dev. 10, 106–113 (2000).
  Article CAS PubMed Google Scholar
• Marx, J. Debate surges over the origins of genomic defects in cancer. Science 297, 544–546 (2002).
  Article CAS PubMed Google Scholar
• Jonason, A.S. et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl. Acad. Sci. USA 93, 14025–14029 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Deng, G., Lu, Y., Zlotnikov, G., Thor, A.D. & Smith, H.S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274, 2057–2059 (1996).
  Article CAS PubMed Google Scholar
• Rehman, I., Quinn, A.G., Healy, E. & Rees, J.L. High frequency of loss of heterozygosity in actinic keratoses, a usually benign disease. Lancet 344, 788–789 (1994).
  Article CAS PubMed Google Scholar
• Gong, G. et al. Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin. Cancer Res. 7, 2410–2414 (2001).
  CAS PubMed Google Scholar
• Shaaban, A.M. et al. Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J. Surg. Pathol. 26, 421–430 (2002).
  Article CAS PubMed Google Scholar
• Brown, K., Strathdee, D., Bryson, S., Lambie, W. & Balmain, A. The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted. Curr. Biol. 8, 516–524 (1998).
  Article CAS PubMed Google Scholar
• Pinkel, D. et al. Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc. Natl. Acad. Sci. USA 85, 9138–9142 (1988).
  Article CAS PubMed PubMed Central Google Scholar
• Gray, J.W. & Collins, C. Genome changes and gene expression in human solid tumors. Carcinogenesis 21, 443–452 (2000).
  Article CAS PubMed Google Scholar
• Hayashizaki, Y. et al. Restriction landmark genomic scanning method and its various applications. Electrophoresis 14, 251–258 (1993).
  Article CAS PubMed Google Scholar
• Kallioniemi, A. et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258, 818–821 (1992).
  Article CAS PubMed Google Scholar
• Ginzinger, D.G. et al. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res. 60, 5405–5409 (2000).
  CAS PubMed Google Scholar
• Lisitsyn, N. & Wigler, M. Cloning the differences between two complex genomes. Science 259, 946–951 (1993).
  Article CAS PubMed Google Scholar
• Zardo, G. et al. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat. Genet. 32, 453–458 (2002).
  Article CAS PubMed Google Scholar
• Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949–954 (2002).
  Article CAS PubMed Google Scholar
• Schena, M., Shalon, D., Davis, R.W. & Brown, P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467–470 (1995).
  Article CAS PubMed Google Scholar
• Bernard, P.S. & Wittwer, C.T. Real-time PCR technology for cancer diagnostics. Clin. Chem. 48, 1178–1185 (2002).
  CAS PubMed Google Scholar
• Conrads, T.P., Anderson, G.A., Veenstra, T.D., Pasa-Tolic, L. & Smith, R.D. Utility of accurate mass tags for proteome-wide protein identification. Anal Chem. 72, 3349–3354 (2000).
  Article CAS PubMed Google Scholar
• Knezevic, V. et al. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 1, 1271–1278 (2001).
  Article CAS PubMed Google Scholar
• Heisterkamp, N., Stam, K., Groffen, J., de Klein, A. & Grosveld, G. Structural organization of the BCR gene and its role in the Ph′ translocation. Nature 315, 758–761 (1985).
  Article CAS PubMed Google Scholar
• Bernardi, R., Grisendi, S. & Pandolfi, P.P. Modelling haematopoietic malignancies in the mouse and therapeutical implications. Oncogene 21, 3445–3458 (2002).
  Article CAS PubMed Google Scholar
• Druker, B.J. et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N. Engl. J. Med. 344, 1038–1042 (2001).
  Article CAS PubMed Google Scholar
• Kallioniemi, O.P. et al. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc. Natl. Acad. Sci. USA 89, 5321–5325 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Vogel, C.L. et al. First-line Herceptin monotherapy in metastatic breast cancer. Oncology 61 (suppl. 2), 37–42 (2001).
  Article CAS PubMed Google Scholar
• Lyons, J.F., Wilhelm, S., Hibner, B. & Bollag, G. Discovery of a novel Raf kinase inhibitor. Endocr. Relat. Cancer 8, 219–225 (2001).
  Article CAS PubMed Google Scholar
• Balmain, A. Cancer: new-age tumour suppressors. Nature 417, 235–237 (2002).
  Article CAS PubMed Google Scholar
• Jaenisch R, & Adrian, B. Epigenetic regulation: how the genome integrates intrinsic and environmental signals. Nat. Genet., 33, 245–254 (2003)
  Article CAS PubMed Google Scholar
• Baylin, S. & Bestor, T.H. Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 1, 299–305 (2002).
  Article CAS PubMed Google Scholar
• Jones, P.A. & Baylin, S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415–428 (2002).
  Article CAS PubMed Google Scholar
• Venkatachalam, S. et al. Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J. 17, 4657–4667 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Tang, B. et al. Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency. Nat. Med. 4, 802–807 (1998).
  Article CAS PubMed Google Scholar
• Fero, M.L., Randel, E., Gurley, K.E., Roberts, J.M. & Kemp, C.J. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396, 177–180 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Inoue, K., Zindy, F., Randle, D.H., Rehg, J.E. & Sherr, C.J. Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas. Genes Dev. 15, 2934–2939 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Ji, L. et al. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res. 62, 2715–2720 (2002).
  CAS PubMed PubMed Central Google Scholar
• You, M. et al. Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. Proc. Natl. Acad. Sci. USA 89, 5804–5808 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Linardopoulos, S., Silva, S., Klein, G. & Balmain, A. Allele-specific loss or imbalance of chromosomes 9, 15, and 16 in B-cell tumors from interspecific F1 hybrid mice carrying Emu-c-myc or N-myc transgenes. Int. J. Cancer 88, 920–927 (2000).
  Article CAS PubMed Google Scholar
• Hodgson, G. et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat. Genet. 29, 459–464 (2001).
  Article CAS PubMed Google Scholar
• Sidransky, D. Emerging molecular markers of cancer. Nat. Rev. Cancer 2, 210–219 (2002).
  Article CAS PubMed Google Scholar
• Davies, R.J. et al. Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool. Lancet 359, 1917–1919 (2002).
  Article CAS PubMed Google Scholar
• van de Vijver, M.J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999–2009 (2002).
  Article CAS PubMed Google Scholar
• Albert, R., Jeong, H. & Barabasi, A.L. Error and attack tolerance of complex networks. Nature 406, 378–382 (2000).
  Article CAS PubMed Google Scholar